News

Find out about what's been happening at the Clinic.

a diverse group of people in a park standing together in a line

FutureMS: a new decade of discovery and insight

Mar 2026: Anne Rowling Clinic to launch 10-year recruitment phase of its landmark MS study

MND-SMART: Amantadine Stage 2 Interim Analysis Results

Mar 2026: The results of the second interim analysis have been released.

Winter 2025 newsletter

Dec 2025: Our winter newsletter is now available

The Anne Rowling Clinic building with snowflakes and a snowman

Christmas closure 2025

Dec 2025: Arrangements for research and NHS Lothian outpatient appointments held at the Anne Rowling Clinic over the Festive season.

Hand adding the final piece to wooden jigsaw showing a stylised image of a head and brain. The jigsaw is sitting on grass so there is a green background.

NeuroCARE: 12 months on

Dec 2025: Thank you to everyone who has signed up to NeuroCARE since its launch this year.

Johnny Tam Rowling Scholar with Mr Steven Barrett OBE at the 2025 MRC Max Perutz Awards

Anne Rowling Clinic Researcher Celebrated in The Observer for Award-Winning MND Video

Dec 2025: Dr Johnny Tam wins prestigious MRC Max Perutz Award for Science Communication.

Nurse with patient and partner in a consultation room

ALS-Biomarker study reaches recruitment milestone

Nov 2025: Success for Anne Rowling Clinic researchers in reaching recruitment goal.

UK vaccine trial targets virus linked to MS

Nov 2025: A new clinical trial is set to test whether vaccination against a common virus found in almost all people with multiple sclerosis (MS) could help treat the condition.

A picture of a person and their partner having a discussion with a counsellor in their home.

Understanding Suicidal Thoughts After an MS Diagnosis

Oct 2025: Suicidal ideation in the year following diagnosis of relapsing-remitting multiple sclerosis: A longitudinal perspective.

Dawn Lyle, MS & Neuroimmunology Hub Manager announces her retirement

Oct 2025: After fourteen years at the Anne Rowling Clinic, Dawn Lyle is retiring.

Understanding the long-term safety of interferon-beta treatment for multiple sclerosis

Oct 2025: In a large study led by researchers at the Anne Rowling Clinic, in partnership with scientists from the University of British Columbia (Canada), people with multiple sclerosis who used interferon-beta for a long time were found to have a slightly higher chance of developing heart and blood vessel problems.

head and shoulders image of Bastien Rioux

Bastien Rioux completes PhD on the role of inflammation in brain health

Oct 2025: Dr Bastien Rioux, a Rowling Scholar who has recently completed his PhD thesis, reflects on his research at the Clinic.